🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

8,395 results for “La” Clear

  1. Xiang Sha Liu Jun Zi Decoction dry powder

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule completed

    1 trial

  2. Xolair

    United Therapeutics Europe Ltd

    Atopic Eczema

    approved small molecule completed

    1 trial

  3. Xolair 150 mg solution for injection in pre-filled syringe, Physiological saline

    Disc Medicine

    Carotid artery stenosis

    approved small molecule active

    1 trial

  4. Xolair 75 mg solution for injection in pre-filled syringe

    Pari Pharma GmbH

    Well controlled severe allergic asthma

    approved small molecule active

    1 trial

  5. Xyrem (X)

    Jazz Pharmaceuticals Ireland Limited

    Obstructive Sleep Apnea Syndrome

    approved small molecule completed

    1 trial

  6. Yuflyma 40 mg solution for injection in pre-filled pen, Hyrimoz 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled pen, Humira 40 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Hyrimoz 40 mg solution for injection in pre-filled s

    Lacuna Pharma Pty Ltd

    Rheumatoid arthritis

    approved small molecule active

    1 trial

  7. Zaredrop 75 mg/ml soluzione orale, Laroxyl 40 mg/ml gocce orali soluzione, FLUOXETINA DOC Generici 20 mg/5 ml Soluzione orale, Zoloft 20 mg/ml concentrato per soluzione orale, Brintellix 20 mg/ml oral drops, solution, Daparox 33,1 mg/ml, gocce orali, soluzione., CITALOPRAM ABC 40 mg/ml gocce orali, soluzione, ESCITALOPRAM DOC 20 mg/ml gocce orali, soluzione

    Verona Pharma Ireland Limited

    Patients with currently remitted depressive disorders.

    approved small molecule active

    1 trial

  8. Zeposia 0.92 mg hard capsules

    Verona Pharma Ireland Limited

    Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive)

    approved small molecule active

    1 trial

  9. Zushima plaster with high dose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteoarthritis

    approved small molecule completed

    1 trial

  10. [68Ga]FAPI-46

    Disc Medicine

    post-acute sequelae of COVID-19

    approved small molecule active

    1 trial

  11. adefovir dipivoxil

    GlaxoSmithKline

    Hepatitis B, Chronic

    approved small molecule completed

    1 trial

  12. aflibercept 2.0 mg

    Regeneron UK Limited

    Age Related Macular Degeneration

    approved small molecule completed

    1 trial

  13. aflibercept 2.0 mg

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    1 trial

  14. aripiprazole

    Otsuka Beijing Research Institute

    Bipolar Disorder

    approved small molecule completed

    1 trial

  15. artemether lumefantrine

    United Therapeutics Europe Ltd

    Uncomplicated Malaria

    approved small molecule completed

    1 trial

  16. artemether-lumefantrine (ALN)

    United Therapeutics Europe Ltd

    Uncomplicated Malaria

    approved small molecule completed

    1 trial

  17. aspirin and clopidogrel

    The First People's Hospital of Lianyungang

    Atrial Fibrillation

    approved small molecule active

    1 trial

  18. bimekizumab

    Lacuna Pharma Pty Ltd

    Moderate to Severe Plaque Psoriasis, Psoriatic arthritis

    approved small molecule active

    1 trial

  19. brinzolamide 1%/brimonidine 0.2% fixed combination

    Novartis Pharmaceuticals

    Glaucoma

    approved small molecule completed

    1 trial

  20. buprenorphine

    Indivior Pty Ltd

    Opiate-related Disorders

    approved small molecule completed

    1 trial

  21. cagrilintide, Placebo + Placebo, semaglutide, cagrilintide, cagrilintide semaglutide, semaglutide, semaglutide, semaglutide, cagrilintide semaglutide, semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide, cagrilintide

    NovoThirteen

    Obesity and T2D

    approved small molecule active

    1 trial

  22. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    approved other active

    1 trial

  23. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved other completed

    1 trial

  24. crizotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Systemic Anaplastic Large-Cell Lymphoma

    approved small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources